Medical treatments for patients with cystic<unk>  has targeted following consequences of the defect such as GI and pulmonary mucus plugging and infection. Treatment include mucolytic agents (dornase alfa, N-acetyl-L-cysteine), airway surface rehydration (hypertonic saline, osmotic agents), anti-infective agents (for prophylaxis, eradication of early infection and suppression of chronic infection), anti-inflammatory agents (NSAIDs, inhaled corticosteroids, LTB4 receptor antagonists and Azithromycin) and potentiators of CFTR protein defect.
Cystic fibrosis medical therapy
Alpha 1-antitrypsin deficiency medical therapy
Respiratory disease medical therapy
Chronic obstructive pulmonary disease medical therapy
Adult bronchiolitis medical therapy
Asthma medical therapy
Cystic fibrosis secondary prevention
Protein energy malnutrition medical therapy